Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease.
暂无分享,去创建一个
R E Lenkinski | R I Grossman | R. Lenkinski | R. Grossman | H. Kimura | F Gonzalez-Scarano | F. González-Scarano | H Kimura
[1] P. Hecke,et al. Human brain proton localized NMR spectroscopy in multiple sclerosis , 1991, Magnetic resonance in medicine.
[2] M. Schnall,et al. Magnetization transfer imaging with pulsed off‐resonance saturation: Variation in contrast with saturation duty cycle , 1994, Journal of magnetic resonance imaging : JMRI.
[3] William H. Oldendorf,et al. N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.
[4] T. Richards,et al. Remitting-relapsing EAE in nonhuman primates: a valid model of multiple sclerosis. , 1991, Clinical immunology and immunopathology.
[5] P A Narayana,et al. Proton MR spectroscopy of gadolinium‐enhanced multiple sclerosis plaques , 1992, Journal of magnetic resonance imaging : JMRI.
[6] G J Barker,et al. The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio , 1993, Magnetic resonance in medicine.
[7] R I Grossman,et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. , 1992, Radiology.
[8] J. Coyle,et al. N‐Acetyl‐Aspartyl‐Glutamate: Regional Levels in Rat Brain and the Effects of Brain Lesions as Determined by a New HPLC Method , 1984, Journal of neurochemistry.
[9] D. Paty,et al. Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products , 1993, The Lancet.
[10] I. Allen,et al. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.
[11] D. Gadian,et al. Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis , 1991, The Lancet.
[12] P M Matthews,et al. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.
[13] R I Grossman,et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. , 1995, Radiology.
[14] R S Balaban,et al. Magnetization transfer contrast in magnetic resonance imaging. , 1992, Magnetic resonance quarterly.
[15] P M Matthews,et al. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis , 1991, Neurology.
[16] T. Richards. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. , 1991, AJR. American journal of roentgenology.
[17] G. Barker,et al. Detection of myelin breakdown products by proton magnetic resonance spectroscopy , 1993, The Lancet.
[18] J. Cooper,et al. N‐ACETYL‐l‐ASPARTIC ACID CONTENT OF HUMAN NEURAL TUMOURS AND BOVINE PERIPHERAL NERVOUS TISSUES , 1972, Journal of neurochemistry.
[19] R E Lenkinski,et al. MR proton spectroscopy in multiple sclerosis. , 1992, AJNR. American journal of neuroradiology.
[20] R I Grossman,et al. Dyke Award paper. MR of wallerian degeneration in the feline visual system: characterization by magnetization transfer rate with histopathologic correlation. , 1994, AJNR. American journal of neuroradiology.
[21] R E Lenkinski,et al. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis , 1994, Magnetic resonance in medicine.
[22] Ad Bax,et al. Improved solvent suppression in one-and two-dimensional NMR spectra by convolution of time-domain data , 1989 .
[23] R. Balaban,et al. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.